1. Everolimus-eluting bioresorabable scaffold system in the treatment of cardiac allograft vasculopathy: the cardiac allograft reparative therapy (CART) prospective multicentre pilot study. (3rd October 2022) Authors: Pighi, M; Tomai, F; Fezzi, S; Pesarini, G; Petrolini, A; Spedicato, L; Tarantini, G; Ferlini, M; Calabro, P; Loi, B; Tovar Forero, N; Daemen, J; Ribichini, F T Journal: European heart journal Issue: Volume 43(2022)Supplement 2 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Effect of body mass index on ischemic and bleeding events in patients presenting with acute coronary syndromes: insights from the START-ANTIPLATELET registry. (25th November 2020) Authors: Moscarella, E; Calabro, P; Gragnano, F; Cesaro, A; Pafundi, P.C; Patti, G; Cavallari, I; Antonucci, E; Cirillo, P; Pignatelli, P; Palareti, G; Sasso, F.C; Pengo, V; Gresele, P; Marcucci, R Journal: European heart journal Issue: Volume 41:(2020)Supplement 2 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗